图表注意力融合与科尔莫戈罗夫-阿诺德药物基因相互作用预测网络
IEEE journal of biomedical and health informatics
|December 11, 2025
概括
本研究介绍了dgKAN,这是一种使用图表注意力和Kolmogorov-Arnold网络 (KAN) 预测药物基因相互作用的新型深度学习模型. dgKAN有效地分析复杂的关系,提高药物发现潜力.
科学领域:
- 计算生物学是一种计算生物学.
- 药物基因组学 药物基因组学
- 人工智能在药物发现中的作用
背景情况:
- 预测药物基因相互作用对于药物开发至关重要.
- 了解深度学习模型中注意力机制的影响对于复杂的数据集至关重要.
- 现有的方法可能无法完全捕捉药物和基因特征之间的复杂相互作用.
研究的目的:
- 提出一种新的深度学习框架,dgKAN,用于准确预测药物基因相互作用.
- 开发一种可解释的模型,分析药物-基因关系中异质注意力的相互影响.
- 通过识别潜在的治疗标和候选药物来增强药物发现.
主要方法:
- 使用动态邻居选择和注意力采样构建子图,用于药物和基因嵌入.
- 使用变压器和图形神经网络 (TransGNN) 模块来融合全球和本地注意力机制.
- 开发一个可解释的Kolmogorov-Arnold网络 (KAN) 具有spline函数来建模跨域信息流.
主要成果:
- 在各种数据集中,dgKAN在药物基因相互作用预测方面显著优于现有的基线方法.
- 该模型通过分析药物-基因关系中的异质注意力,成功捕捉了隐性特征.
- 由于KAN网络的可解释性,可以更深入地了解模型的决策过程.
结论:
- dgKAN代表了用于药物基因相互作用预测的深度学习的重大进步.
- 这种方法为药物和基因之间的复杂关系提供了宝贵的见解.
- 预测的相互作用具有加速药物开发和改善疾病治疗策略的巨大潜力.
相关概念视频
Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K
Protein Networks
4.4K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.4K
Protein Networks
2.7K
2.7K
Drug-Receptor Interactions
7.2K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.2K
Quantitative Aspects of Drug-Receptor Interaction
1.7K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.7K
Drug-Receptor Interaction: Agonist
3.7K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
3.7K


